There is a lot of reassuring evidence that suggests there is no increased risk of blood clots from AstraZeneca’s coronavirus vaccine, England’s deputy chief medical officer announced on Wednesday, noting that he expected the European Medicines Agency to agree.

“Behind the scenes, there is a lot of work going on to look at whether there is a signal in relation to what we call venous thrombo-embolic events – clots,” Jonathan Van-Tam said at a news conference today.

“And there’s a lot of evidence emerging now that is reassuring that there is no overall excess signal or increased risk. And I expect, without prejudice to their absolute findings, those to be the final conclusions of the EMA and (Britain’s) MHRA in due course.”